Viewing Study NCT00673504


Ignite Creation Date: 2025-12-24 @ 7:59 PM
Ignite Modification Date: 2025-12-30 @ 7:31 AM
Study NCT ID: NCT00673504
Status: COMPLETED
Last Update Posted: 2011-12-01
First Post: 2008-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: First-Line Gemcitabine Chemotherapy With Our Without Sunitinib In Advanced or Metastatic Pancreatic Cancer
Sponsor: Central European Society for Anticancer Drug Research
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module